Pricing Log in Create free account

Alterity Therapeutics Limited - Sponsored ADR (ATHE) vs RenovoRx, Inc. (RNXT)

Alterity Therapeutics Limited - Sponsored ADR and RenovoRx, Inc. are both Biotechnology companies. Alterity Therapeutics Limited - Sponsored ADR and RenovoRx, Inc. are of similar size ($53.7M and $52.0M). Alterity Therapeutics Limited - Sponsored ADR has the higher net margin (0.00% vs −621.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Alterity Therapeutics Limited - Sponsored ADR leads on 7 and RenovoRx, Inc. on 3.

Valuation

Metric ATHE RNXT Biotechnology median
P/E n/m n/m 8.50
P/S n/m 27.53 9.71
P/B n/m 6.06 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.94 n/m 0.64
EV/Sales n/m 25.16 9.21
Earnings yield 0.00% (26.96%) (33.15%)
Free cash flow yield 0.00% (21.95%) (25.50%)

Profitability

Metric ATHE RNXT Biotechnology median
Gross margin 0.00% 84.41% 65.16%
Operating margin — (685.22%) 0.00%
Net margin 0.00% (621.71%) 0.00%
Free cash flow margin 0.00% (604.10%) 0.00%
Return on equity 0.00% (125.23%) (56.36%)
Return on assets 0.00% (97.83%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATHE RNXT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (22.97%) 20.00% 30.26%
Revenue growth, 5-year CAGR (1.15%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATHE RNXT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.52 5.74 4.72
Net debt to EBITDA 1.32 0.56 0.96

Dividend

Metric ATHE RNXT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATHE RNXT Biotechnology median
Market cap 51.95m 53.71m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack